Financial
Sales growth, a completed merger and FDA approval highlight third quarter for Wright Medical
By Michael Sheffield
Memphis-based Wright Medical Group saw a 12 percent increase in sales for the third quarter of 2015.
The company, which completed its merger with Netherlands-based Tournier N.V. on Oct. 1, reported net sales of $80.1 million for the third quarter, compared to $71.3 million in the third quarter of 2014. Wright Medical’s sales for the first nine months of the year were $238.4 million.
The company saw its net loss increase year over year to $62.7 million, or $1.22 per diluted share, compared to $49.6 million, or 99 cents per diluted share, for the same time last year.
